Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats

Journal of Nutritional Science and Vitaminology

Volumn 54, Issue 4, 2008, Pages 321-328

  Cui, Xiao Pei ^a   Li, Bao Ying ^a   Gao, Hai Qing ^a   Wei, Na ^a   Wang, Wei Ling ^a   Lu, Mei ^a  

^a Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

Author keywords

Diabetic peripheral neuropathy; Grape seed proanthocyanidin extracts; Mechanical allodynia; Motor nerve conductive velocity; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GRAPE SEED EXTRACT; HEMOGLOBIN A1C; MALONALDEHYDE; PROANTHOCYANIDIN; SUPEROXIDE DISMUTASE; GRAPE SEED PROANTHOCYANIDINS; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEMYELINATION; DIABETIC NEUROPATHY; DRUG MECHANISM; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERALGESIA; MALE; MOTOR NERVE CONDUCTION; NERVE INJURY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM FUNCTION; RAT; SCHWANN CELL; TISSUE LEVEL; ULTRASTRUCTURE; ANIMAL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GRAPE; PAIN THRESHOLD; PATHOLOGY; SCIATIC NERVE; WISTAR RAT;

RATTUS; VITACEAE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; MALE; OXIDATIVE STRESS; PAIN THRESHOLD; PLANT EXTRACTS; PROANTHOCYANIDINS; RATS; RATS, WISTAR; SCIATIC NERVE; VITIS;

EID: 59049102102     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.54.321     Document Type: Article

References (35)

1. Argoff CE, Cole BE, Fishbain DA, Irving GA. 2006. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 81: S3-S11.
2. Vinik AI, Mehrabyan A. 2004. Diabetic neuropathies. Med Clin North Am 88: 947-999, xi.
3. Baynes JW, Thorpe SR. 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9.
4. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
5. The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
6. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. 2000. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49: 1006-1015.
7. Kumar A, Kaundal RK, Iyer S, Sharma SS. 2007. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci 80: 1236-1244.
8. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ. 1997. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 95: 179-189.
9. 2/NaOH/DMSO system. J Agric Food Chem 47: 2544-2548.
10. Shao ZH, Vanden Hoek TL, Li CQ, Schumacker PT, Becker LB, Chan KC, Qin Y, Yin JJ, Yuan CS. 2004. Synergistic effect of Scutellaria baicalensis and grape seed proanthocyanidins on scavenging reactive oxygen species in vitro. Am J Chin Med 32: 89-95.
11. Du Y, Guo H, Lou H. 2007. Grape seed polyphenols protect cardiac cells from apoptosis via induction of endogenous antioxidant enzymes. J Agric Food Chem 55: 1695-1701.
12. Feng Y, Liu YM, Leblanc MH, Bhatt AJ, Rhodes PG. 2007. Grape seed extract given three hours after injury suppresses lipid peroxidation and reduces hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 61: 295-300.
13. Liu YN, Shen XN, Yao GY. 2006. Effects of grape seed proanthocyanidins extracts on experimental diabetic nephropathy in rats. Wei Sheng Yah Jiu 35: 703-705.
14. Iwasaki Y, Matsui T, Arakawa Y. 2004. The protective and hormonal effects of proanthocyanidin against gastric mucosal injury in Wistar rats. J Gastroenterol 39: 831-837.
15. Baynes JW. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
16. Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, Matsumura T, Araki E. 2007. Impact of mitochondrial ROS production on diabetic vascular complications. Diabetes Res Clin Pract 77 (Suppl 1): S41-S45.
17. Iida H, Schmeichel AM, Wang Y, Schmelzer JD, Low PA. 2004. Schwann cell is a target in ischemia-reperfusion injury to peripheral nerve. Muscle Nerve 30: 761-766.
18. Anwer T, Sharma M, Pillai KK, Haque SE, Alam MM, Zaman MS. 2007. Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats. Toxicology 229: 165-172.
19. Plumb GW, De Pascual-Teresa S, Santos-Buelga C, Cheynier V, Williamson G. 1998. Antioxidant properties of catechins and proanthocyanidins: effect of polymerisation, galloylation and glycosylation. Free Radio Res 29: 351-358.
20. Fujii H, Yokozawa T, Kim YA, Tohda C, Nonaka G. 2006. Protective effect of grape seed polyphenols against high glucose-induced oxidative stress. Biosci Biotechnol Biochem 70: 2104-2111.
21. Zhang FL, Gao HQ, Wu JM, Ma YB, You BA, Li BY, Xuan JH. 2006. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advanced glycation end products in endothelial cells. J Cardiovasc Pharmacol 48: 47-53.
22. Thornalley PJ, Langborg A, Minhas HS. 1999. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344 (Pt 1): 109-116.
23. Russell JW, Sullivan KA, Windebank AJ. Herrmann DN, Feldman EL. 1999. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6: 347-363.
24. Luo Y, Umegaki H, Wang X. Abe R, Roth GS. 1998. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 275: 3756-3764.
25. Zhou Y. Ma Y-b, Gao H-q, et al. 2005. Experiment study on anti-nonenzyme glycosylation effect of grape seed proanthocyanidin extract in diabetic rats. Chin J Geriatr 24: 47-52.
26. Chang PC, Chen TH, Chang CJ, Hou CC, Chan P, Lee HM. 2004, Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. Kidney Int 65: 1664-1675.
27. Feldman EL. Stevens MJ, Greene DA. 1997. Pathogenesis of diabetic neuropathy. Clin Neurosci 4: 365-370.
28. Thomas PK. 1999. Diabetic neuropathy: mechanisms and future treatment options. J Neurol Neurosurg Psychiatry 67: 277-279.
29. Muona P, Sollberg S, Peltonen J, Uitto J. 1992. Glucose transporters of rat peripheral nerve. Differential expression of GLUT1 gene by Schwann cells and perineural cells in vivo and in vitro. Diabetes 41: 1587-1596.
30. Walker D, Carrington A, Cannan SA, Sawicki D, Sredy J, Boulton AJ, Malik RA. 1999. Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat. J Anat 195 (Pt 3): 419-427.
31. Li F, Obrosova IG, Abatan O, Tian D, Larkin D, Stuenkel EL, Stevens MJ. 2005. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab 288: E29-E36.
32. Hong S, Morrow TJ, Paulson PE, Isom LL, Wiley JW. 2004. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem 279: 29341-29350.
33. Sharma S, Kulkarni SK, Chopra K. 2007. Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundanl Clin Pharnlacol 21: 89-94.
34. Matsunaga A, Kawamoto M, Shiraishi S, Yasuda T, Kajiyama S, Kurita S, Yuge O, 2007. Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. Eur J Pharmacol 554:12-17.
35. Zhang W, Murakawa Y, Wozniak KM, Slusher B, Sima AA. 2006. The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy. J Neurol Sci 247: 217-223.